Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adebrelimab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06464614
What this trial is testing

Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC.

Who this might be right for
Esophageal Cancer
The First Affiliated Hospital of Henan University of Science and Technology 54
Large-scale testing (Phase 3)Looking for participantsNCT06618664
What this trial is testing

A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab or Atezolizumab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 590
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06480136
What this trial is testing

SHR-A1921 Combined With Adebrelimab in the Treatment of Advanced NSCLC Who Failed the Previous Standard First-line Treatment

Who this might be right for
NSCLC
Shanghai Pulmonary Hospital, Shanghai, China 32
Testing effectiveness (Phase 2)UnknownNCT05932264
What this trial is testing

Apatinib and Fluzoparib With or Without Adebrelimab in Previously-treated TP53-mutant Advanced Non-small Cell Lung Cancer

Who this might be right for
NSCLCNon-small Cell Lung Cancer
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06600841
What this trial is testing

Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer

Who this might be right for
Platinum-resistant Ovarian Cancer (PROC)Immunotherapy
Fujian Cancer Hospital 37
Large-scale testing (Phase 3)Not Yet RecruitingNCT07822542
What this trial is testing

A Study Evaluating HS-10370 Plus Platinum-based Doublet Chemotherapy With or Without Adebrelimab vs. Tislelizumab Plus Chemotherapy as First-Line Therapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Jiangsu Hansoh Pharmaceutical Co., Ltd. 448
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06306560
What this trial is testing

Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Harbin Medical University 40
Large-scale testing (Phase 3)Looking for participantsNCT07679360
What this trial is testing

Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in Subjects With Residual Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07704177
What this trial is testing

Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib in Advanced HER2-Positive/Low-Expression Biliary Tract Cancer

Who this might be right for
Biliary Tract Neoplasms Immunotherapy
Peking Union Medical College Hospital 70
Not applicableNot Yet RecruitingNCT07173244
What this trial is testing

A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerSmall Cell Lung CancerGastrointestinal Cancers
Tianjin First Central Hospital 300
Testing effectiveness (Phase 2)Looking for participantsNCT07059221
What this trial is testing

A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 210
Not applicableUnknownNCT06323265
What this trial is testing

A Real-world Study of Adebrelimab Combined With Chemotherapy±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Hebei Medical University Fourth Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT07135544
What this trial is testing

A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerBiliary Tract Cancer (CCA)
Yongjun Chen 37
Testing effectiveness (Phase 2)Looking for participantsNCT06415669
What this trial is testing

Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric/Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital of Xiamen University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06300424
What this trial is testing

Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLC

Who this might be right for
Non Small Cell Lung CancerEGFR Gene Mutation
Guangdong Provincial People's Hospital 32
Testing effectiveness (Phase 2)Looking for participantsNCT07668453
What this trial is testing

An Open-label, Single-arm, Multicenter Exploratory Study of Adebrelimab Combined With Gemcitabine and Albumin-bound Paclitaxel as First-line Treatment for Biliary Tract Malignancies

Who this might be right for
Biliary Tract Neoplasms
The First Affiliated Hospital with Nanjing Medical University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07583550
What this trial is testing

Low-dose Thoracic Radiotherapy Followed by Adebrelimab Plus Chemotherapy, and Then Sequential Maintenance Therapy With Adebrelimab for Extensive-stage Small Cell Lung Cancer

Who this might be right for
LungRadiotherapy
Jiangmen Central Hospital 43
Testing effectiveness (Phase 2)Looking for participantsNCT06500208
What this trial is testing

Neoadjuvant Adebrelimab and Chemotherapy in High-rish ER+/HER2- BC

Who this might be right for
Breast Cancer
Shanghai Jiao Tong University School of Medicine 48
Testing effectiveness (Phase 2)Looking for participantsNCT06177925
What this trial is testing

A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC

Who this might be right for
Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by Site+7 more
Nanfang Hospital, Southern Medical University 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT06700421
What this trial is testing

Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis

Who this might be right for
Unresectable Locally Advanced Non-small Cell Lung Cancer
Wei Zhou 32
Next Page